Mod­er­na's Stéphane Ban­cel plans to dou­ble down on vac­cine pro­duc­tion, new vari­ants as mR­NA rules in pan­dem­ic fight

Stéphane Ban­cel thought he’d be sleep­ing more by now.

The 48-year-old Mod­er­na CEO fig­ured that by 2021 he’d have his vac­cine through the clin­ic, au­tho­rized, and in mass pro­duc­tion — that the hard part would be over. In­stead, he’s still work­ing Sat­ur­days and Sun­days, talk­ing with his lab and man­u­fac­tur­ing teams and field­ing calls with two to three world lead­ers a day to an­swer their con­cerns about sup­ply and emerg­ing new vari­ants.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA